Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver-prognosis in chronic hepatitis C

Published:2014-06-02 Issue:2 Volume:40 Page:178-188
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Boursier J.¹²,Brochard C.¹,Bertrais S.²,Michalak S.³,Gallois Y.²⁴,Fouchard-Hubert I.¹²,Oberti F.¹²,Rousselet M.-C.²³,Calès P.¹²

Affiliation:

1. Liver-Gastroenterology Department; University Hospital; Angers France

2. HIFIH Laboratory; UPRES 3859, SFR 4208; LUNAM University; Angers France

3. Pathology Department; University Hospital; Angers France

4. Biochemistry Department; University Hospital; Angers France

Funder

University Hospital of Angers

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12813/fullpdf

Reference35 articles.

1. Reproducibility of blood tests of liver fibrosis in clinical practice;Cales;Clin Biochem,2008

2. Clinical practice guidelines: management of hepatitis C virus infection;EASL;J Hepatol,2011

3. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

4. Liver biopsy: the best, not the gold standard;Bedossa;J Hepatol,2009

5. Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay;Mayo;Hepatology,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repeated Measurement of FIB-4 to Predict Long-Term Risk of HCC Development Up to 10 Years After SVR;Journal of Hepatocellular Carcinoma;2022-12

2. Role of liver biopsy versus non-invasive biomarkers for diagnosis of significant fibrosis and cirrhosis: a web-based survey;Egyptian Liver Journal;2021-12

3. Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease;Journal of Hepatology;2021-11

4. Validation of the liver traffic light test as a predictive model for survival and development of liver‐related events;JGH Open;2021-03-27

5. Prediction of Patient Survival Following Hepatic Resection in Early-Stage Hepatocellular Carcinoma with Indexed Ratios of Aspartate Aminotransferase to Platelets: A Retrospective Cohort Study;Cancer Management and Research;2021-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3